The tryptophan system in cocaine-induced depression
Major depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use disorder (CUD). The comorbid MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced MDD (CUD-induced-MDD), and their accurate diagnoses and treatment is a challenge for improving prognoses. Thi...
| Autores: | , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2020 |
| País: | España |
| Institución: | Universitat Pompeu Fabra |
| Repositorio: | Repositorio Digital de la UPF |
| OAI Identifier: | oai:repositori.upf.edu:10230/48696 |
| Acceso en línea: | http://hdl.handle.net/10230/48696 http://dx.doi.org/10.3390/jcm9124103 |
| Access Level: | acceso abierto |
| Palabra clave: | Cocaine use disorder Kynurenine Primary/substance-induced depression Serotonin Tryptophan |
| id |
ES_c4b62364555e4b8fc86d16a6748a8da4 |
|---|---|
| oai_identifier_str |
oai:repositori.upf.edu:10230/48696 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
The tryptophan system in cocaine-induced depressionFonseca Casals, Francina, 1972-Mestre-Pintó, Juan IgnacioGómez-Gómez, ÀlexMartínez-Sanvisens, DianaRodríguez-Minguela, RocíoPapaseit Fontanet, EstherPérez Mañá, ClaraLangohr, KlausValverde Granados, OlgaPozo Mendoza, Óscar J., 1975-Farré Albaladejo, MagíPérez Mañá, ClaraNeurodep GroupCocaine use disorderKynureninePrimary/substance-induced depressionSerotoninTryptophanMajor depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use disorder (CUD). The comorbid MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced MDD (CUD-induced-MDD), and their accurate diagnoses and treatment is a challenge for improving prognoses. This study aimed to assess the tryptophan/serotonin (Trp/5-HT) system with the acute tryptophan depletion test (ATD), and the kynurenine pathway in subjects with CUD-primary-MDD, CUD-induced-MDD, MDD and healthy controls. The ATD was performed with a randomized, double-blind, crossover, and placebo-controlled design. Markers of enzymatic activity of indoleamine 2,3-dioxygenase/tryptophan 2,3-dioxygenase, kynurenine aminotransferase (KAT) and kynureninase were also established. Following ATD, we observed a decrease in Trp levels in all groups. Comparison between CUD-induced-MDD and MDD revealed significant differences in 5-HT plasma concentrations (512 + 332 ng/mL vs. 107 + 127 ng/mL, p = 0.039) and the Kyn/5-HT ratio (11 + 15 vs. 112 + 136; p = 0.012), whereas there were no differences between CUD-primary-MDD and MDD. Effect size coefficients show a gradient for all targeted markers (d range 0.72-1.67). Results suggest different pathogenesis for CUD-induced-MDD, with lower participation of the tryptophan system, probably more related to other neurotransmitter pathways and accordingly suggesting the need for a different pharmacological treatment approach.This work was supported by grants from the Instituto de Salud Carlos III–ISCIII Red de Trastornos Adictivos 2016 (RD16/0017/0010, RD16/0017/0003; Fondo de Investigación Sanitaria (FIS) (PI09/02121, PI12/01838, PI14/00178, PI16/00603); National R + D+I and funded by the Instituto de Salud Carlos III (ISCIII) and the European Regional Development Fund (FEDER) grant Juan Rodes (JR 16/00020); Ministerio de Sanidad, Política Social e Igualdad, Plan Nacional Sobre Drogas (PNSD) (2012I054); Suport Grups de Recerca AGAUR-Gencat (2017 SGR 316, 2017 SGR 530); Acció instrumental d’Intensificació de Professionals de la Salut - Facultatius especialistes (PERIS) (SLT006/17/00014); and Ministerio de Economía y Competitividad (MTM2015-64465-C2-1-R). The funding agencies had no role in study design, data collection, interpretation, or had influence on the writing.MDPI202120212020info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/48696http://dx.doi.org/10.3390/jcm9124103reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésinfo:eu-repo/grantAgreement/ES/1PE/MTM2015-64465-C2-1-RCopyright © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).http://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/486962026-06-12T07:21:37Z |
| dc.title.none.fl_str_mv |
The tryptophan system in cocaine-induced depression |
| title |
The tryptophan system in cocaine-induced depression |
| spellingShingle |
The tryptophan system in cocaine-induced depression Fonseca Casals, Francina, 1972- Cocaine use disorder Kynurenine Primary/substance-induced depression Serotonin Tryptophan |
| title_short |
The tryptophan system in cocaine-induced depression |
| title_full |
The tryptophan system in cocaine-induced depression |
| title_fullStr |
The tryptophan system in cocaine-induced depression |
| title_full_unstemmed |
The tryptophan system in cocaine-induced depression |
| title_sort |
The tryptophan system in cocaine-induced depression |
| dc.creator.none.fl_str_mv |
Fonseca Casals, Francina, 1972- Mestre-Pintó, Juan Ignacio Gómez-Gómez, Àlex Martínez-Sanvisens, Diana Rodríguez-Minguela, Rocío Papaseit Fontanet, Esther Pérez Mañá, Clara Langohr, Klaus Valverde Granados, Olga Pozo Mendoza, Óscar J., 1975- Farré Albaladejo, Magí Pérez Mañá, Clara Neurodep Group |
| author |
Fonseca Casals, Francina, 1972- |
| author_facet |
Fonseca Casals, Francina, 1972- Mestre-Pintó, Juan Ignacio Gómez-Gómez, Àlex Martínez-Sanvisens, Diana Rodríguez-Minguela, Rocío Papaseit Fontanet, Esther Pérez Mañá, Clara Langohr, Klaus Valverde Granados, Olga Pozo Mendoza, Óscar J., 1975- Farré Albaladejo, Magí Neurodep Group |
| author_role |
author |
| author2 |
Mestre-Pintó, Juan Ignacio Gómez-Gómez, Àlex Martínez-Sanvisens, Diana Rodríguez-Minguela, Rocío Papaseit Fontanet, Esther Pérez Mañá, Clara Langohr, Klaus Valverde Granados, Olga Pozo Mendoza, Óscar J., 1975- Farré Albaladejo, Magí Neurodep Group |
| author2_role |
author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Cocaine use disorder Kynurenine Primary/substance-induced depression Serotonin Tryptophan |
| topic |
Cocaine use disorder Kynurenine Primary/substance-induced depression Serotonin Tryptophan |
| description |
Major depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use disorder (CUD). The comorbid MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced MDD (CUD-induced-MDD), and their accurate diagnoses and treatment is a challenge for improving prognoses. This study aimed to assess the tryptophan/serotonin (Trp/5-HT) system with the acute tryptophan depletion test (ATD), and the kynurenine pathway in subjects with CUD-primary-MDD, CUD-induced-MDD, MDD and healthy controls. The ATD was performed with a randomized, double-blind, crossover, and placebo-controlled design. Markers of enzymatic activity of indoleamine 2,3-dioxygenase/tryptophan 2,3-dioxygenase, kynurenine aminotransferase (KAT) and kynureninase were also established. Following ATD, we observed a decrease in Trp levels in all groups. Comparison between CUD-induced-MDD and MDD revealed significant differences in 5-HT plasma concentrations (512 + 332 ng/mL vs. 107 + 127 ng/mL, p = 0.039) and the Kyn/5-HT ratio (11 + 15 vs. 112 + 136; p = 0.012), whereas there were no differences between CUD-primary-MDD and MDD. Effect size coefficients show a gradient for all targeted markers (d range 0.72-1.67). Results suggest different pathogenesis for CUD-induced-MDD, with lower participation of the tryptophan system, probably more related to other neurotransmitter pathways and accordingly suggesting the need for a different pharmacological treatment approach. |
| publishDate |
2020 |
| dc.date.none.fl_str_mv |
2020 2021 2021 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10230/48696 http://dx.doi.org/10.3390/jcm9124103 |
| url |
http://hdl.handle.net/10230/48696 http://dx.doi.org/10.3390/jcm9124103 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
info:eu-repo/grantAgreement/ES/1PE/MTM2015-64465-C2-1-R |
| dc.rights.none.fl_str_mv |
http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
MDPI |
| publisher.none.fl_str_mv |
MDPI |
| dc.source.none.fl_str_mv |
reponame:Repositorio Digital de la UPF instname:Universitat Pompeu Fabra |
| instname_str |
Universitat Pompeu Fabra |
| reponame_str |
Repositorio Digital de la UPF |
| collection |
Repositorio Digital de la UPF |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869418925901479937 |
| score |
15,811543 |